This site is intended for health professionals only
Thursday 27 June 2019
Share |

Topic: migraine

April 19, 2018
<p>Novartis announces Aimovig&trade; could be an effective preventive treatment option for episodic migraine patients where previous treatments have failed</p>

A treatment for patients with episodic migraines could at least halve the number of days they experience them every month, researchers have found.

 

This April, healthcare organisation Novartis announced the results of a study that looked specifically at episodic migraine patients who had previously failed 2 to 4 preventive treatments, due to lack of efficacy and/or intolerable side effects.

 

January 29, 2018
A study led by the University of Warwick in the UK could help thousands of headache sufferers

Researchers at Warwick Medical School are investigating whether a new education and self-management programme will help improve quality of life for people living with chronic headaches.
 

The study, Chronic Headache Education and Self-management Study (CHESS), is funded by the National Institute for Health Research, and is led by Professor Martin Underwood.  
 

November 30, 2017
Patients with episodic migraine taking erenumab reported significant and meaningful benefits over six months, with reduced migraine days and acute medication use

Novartis has announced that the New England Journal of Medicine (NEJM) published positive results from the six-month Phase III STRIVE study evaluating erenumab in the prevention of episodic migraine (defined in STRIVE as 4 to 14 migraine days per month).1

 

October 18, 2010
US health officials have approved the use of the wrinkle-smoothing injection Botox on patients who suffer from migraine headaches

teaser

June 25, 2009
A signalling molecule in the brain linked to male sexual arousal may unlock potential treatments for migraine, chronic pain, epilepsy and Alzheimer's disease

teaser

February 23, 2009
Lacosamide in migraine prophylaxis and rotigotine in fibromyalgia syndrome did not achieve statistical significance for their primary endpoints

teaser

October 21, 2008
Hope for migraine sufferers as new drug could relieve pain by 66%

teaser

You are leaving www.nursinginpractice.com

You are currently leaving the Nursing in Practice site. Are you sure you want to proceed?

Close

Respect for nurses: Sign up to our e-petition TODAY

The Nursing in Practice Respect campaign is now live! Over the coming months, we're set to highlight the vital contribution and efforts of primary care and community care nurses throughout the UK.

As part of our campaign, Nursing in Practice is looking to call on parliament to set up a debate to celebrate the vital work that you do.


GET INVOLVED: SIGN OUR E-PETITION

Close

Calling all primary care nurses! 'Like' our Nursing in Practice Facebook page to enter our free draw to win a £25 M&S voucher




http://www.facebook.com/NursinginPracticeMagazine